Monophasic Action Potential Recording

Monophasic Action Potential Recording (MAP) is an electrophysiological technique used to measure the action potential waveform of cardiac tissue in vivo or in vitro. Unlike traditional transmembrane potential recordings, which require impalement of a cell with microelectrodes, MAP recording captures a near-intracellular action potential from the surface of the myocardium using a specialized electrode that maintains close contact without penetrating the cell membrane. This method provides critical information about the electrical activity and repolarization properties of cardiac muscle, enabling detailed study of cardiac electrophysiology under physiological and experimental conditions.

Principles of Monophasic Action Potential Recording

Electrophysiological Basis

The action potential of cardiac myocytes is a rapid change in membrane potential caused by ion fluxes through voltage-gated channels. The monophasic action potential represents a local extracellular recording that closely approximates the shape and duration of the transmembrane action potential. It reflects phases 0 through 3 of the cardiac action potential, including depolarization, plateau, and repolarization.

The MAP electrode applies slight pressure to the cardiac surface, causing partial depolarization of the underlying cells and electrical coupling between the electrode and the cell membrane. This creates a stable, quasi-intracellular recording without penetrating the cell, allowing the extracellular electrode to follow the transmembrane voltage changes with high fidelity.

Signal Characteristics

The MAP waveform has distinct phases resembling the transmembrane action potential:

• Phase 0 (Rapid Depolarization): A steep upstroke corresponding to sodium ion influx.
• Phase 1 (Initial Repolarization): A small notch due to transient outward potassium current.
• Phase 2 (Plateau Phase): Sustained depolarization caused by calcium influx balancing potassium efflux.
• Phase 3 (Repolarization): Repolarization due to potassium efflux restoring resting potential.
• Phase 4 (Resting Potential): Stable baseline representing resting membrane potential.

The duration and amplitude of the MAP waveform provide insights into cardiac electrophysiological properties such as action potential duration (APD), conduction velocity, and refractoriness.

Equipment and Methodology

Electrode Design

MAP recording uses a contact electrode typically made from materials such as silver-silver chloride or platinum-iridium. The electrode tip is flat or slightly concave to maximize surface contact with the myocardium. It is connected to a high-impedance amplifier to minimize signal distortion.

Recording Setup

1. Electrode Placement: The MAP electrode is positioned against the epicardial or endocardial surface, often stabilized with gentle pressure to maintain consistent contact.
2. Signal Amplification: The small electrical signals are amplified and filtered to remove noise and baseline drift.
3. Data Acquisition: Signals are digitized for real-time display and analysis using specialized software.

Experimental Conditions

MAP recordings can be performed in isolated heart preparations (e.g., Langendorff-perfused hearts), animal models in vivo, or during clinical electrophysiology studies. Temperature, perfusion, and pharmacological agents can be controlled to study their effects on cardiac electrical activity.

Applications of Monophasic Action Potential Recording

Cardiac Electrophysiology Research

MAP recording is fundamental in exploring the mechanisms of cardiac arrhythmias by allowing detailed observation of action potential changes during ischemia, drug administration, or genetic modifications.

Drug Testing and Pharmacology

Evaluation of the effects of anti-arrhythmic drugs or other compounds on action potential duration and shape is frequently performed using MAP recordings, providing insights into proarrhythmic risks and therapeutic efficacy.

Clinical Electrophysiology

In clinical settings, MAP electrodes can be used during catheter-based procedures to assess localized myocardial repolarization and conduction properties, aiding in diagnosis and treatment planning for arrhythmias.

Data Analysis and Interpretation

Action Potential Duration (APD)

APD is measured at specified repolarization percentages, commonly APD50 and APD90, representing the time from depolarization onset to 50% and 90% repolarization, respectively. Changes in APD reflect alterations in ion channel function or pathological conditions.

Signal Morphology

Alterations in the upstroke velocity, plateau height, or repolarization slope can indicate ischemia, fibrosis, or drug effects. The MAP waveform’s morphology is analyzed to detect early afterdepolarizations or delayed repolarization phenomena contributing to arrhythmogenesis.

Quantitative Parameters

Limitations and Considerations

Technical Challenges

Achieving stable and reproducible MAP recordings requires precise electrode positioning and consistent contact pressure. Movement artifacts, signal noise, and tissue heterogeneity can affect data quality.

Interpretation Constraints

Although MAP closely approximates transmembrane action potentials, it remains an extracellular recording and may not fully capture intracellular ionic currents. Careful correlation with other electrophysiological measurements is necessary.

Tissue Damage

Prolonged or excessive pressure from the MAP electrode can cause local tissue injury, altering electrophysiological properties and potentially confounding results.

Summary of Monophasic Action Potential Recording Utility

MAP recording is a valuable tool for real-time, minimally invasive assessment of cardiac electrical activity. It bridges the gap between intracellular microelectrode techniques and surface electrocardiography, providing detailed insights into myocardial electrophysiology under physiological and experimental conditions. Its applications span basic research, pharmacology, and clinical diagnostics, making it a cornerstone method in cardiac electrophysiology.